HUMAN BRCA1 COMPREHENSIVE CROSS-DATABASE IDENTIFIER AND FUNCTIONAL MAPPING REFERENCE
Section 1: Gene Identifiers
| Database | Identifier | Notes |
|---|
| HGNC ID | HGNC:1100 | Approved |
| Approved Symbol | BRCA1 | |
| Approved Name | BRCA1 DNA repair associated | |
| Previous Names | breast cancer 1, early onset; breast cancer 1 | |
| Aliases | RNF53, BRCC1, PPP1R53, FANCS | |
| Ensembl Gene ID | ENSG00000012048 | |
| NCBI Entrez Gene ID | 672 | |
| OMIM Gene ID | 113705 | Gene/locus |
| Locus Group | protein-coding gene | |
| Locus Type | gene with protein product | |
Genomic Location (GRCh38/hg38)
| Parameter | Value |
|---|
| Chromosome | 17 |
| Cytogenetic Band | 17q21.31 |
| Start Position | 43,044,292 |
| End Position | 43,170,245 |
| Strand | Minus (-) |
| Gene Span | 125,954 bp |
Section 2: Transcript Identifiers
Ensembl Transcripts
Total Count: 47 transcripts
| Transcript ID | Biotype | Start | End | Notes |
|---|
| ENST00000357654 | protein_coding | 43044295 | 43125364 | Canonical |
| ENST00000352993 | protein_coding | 43044295 | 43125370 | |
| ENST00000461574 | protein_coding | 43044304 | 43125370 | |
| ENST00000468300 | protein_coding | 43044805 | 43125451 | |
| ENST00000470026 | protein_coding | 43044304 | 43125343 | |
| ENST00000471181 | protein_coding | 43044295 | 43125483 | |
| ENST00000473961 | protein_coding | 43044295 | 43125364 | |
| ENST00000476777 | protein_coding | 43044298 | 43125360 | |
| ENST00000477152 | protein_coding | 43044295 | 43125364 | |
| ENST00000478531 | protein_coding | 43044295 | 43125359 | |
| ENST00000484087 | protein_coding | 43045434 | 43125343 | |
| ENST00000489037 | protein_coding | 43044295 | 43125321 | |
| ENST00000491747 | protein_coding | 43045678 | 43125356 | |
| ENST00000493795 | protein_coding | 43045629 | 43125402 | |
| ENST00000493919 | protein_coding | 43044295 | 43125402 | |
| ENST00000494123 | protein_coding | 43044295 | 43125450 | |
| ENST00000497488 | protein_coding | 43044295 | 43125300 | |
| ENST00000586385 | protein_coding | 43045563 | 43125329 | |
| ENST00000591534 | protein_coding | 43045563 | 43125329 | |
| ENST00000591849 | protein_coding | 43045563 | 43125329 | |
| ENST00000618469 | protein_coding | 43044304 | 43125364 | |
| ENST00000634433 | protein_coding | 43044295 | 43170245 | |
| ENST00000644379 | protein_coding | 43045086 | 43125364 | |
| ENST00000644555 | protein_coding | 43044304 | 43125370 | |
| ENST00000652672 | protein_coding | 43044295 | 43125483 | |
| ENST00000700182 | protein_coding | 43070344 | 43125343 | |
| ENST00000713676 | protein_coding | 43044304 | 43125343 | |
| ENST00000899954 | protein_coding | 43044805 | 43125483 | |
| ENST00000921914 | protein_coding | 43044292 | 43125476 | |
| ENST00000921915 | protein_coding | 43044295 | 43125367 | |
| ENST00000921916 | protein_coding | 43044304 | 43125360 | |
| ENST00000945268 | protein_coding | 43044299 | 43125410 | |
| ENST00000945269 | protein_coding | 43044824 | 43125487 | |
| ENST00000354071 | retained_intron | 43091098 | 43125315 | |
| ENST00000472490 | retained_intron | 43067274 | 43071066 | |
| ENST00000700081 | retained_intron | 43044302 | 43050409 | |
| ENST00000700082 | retained_intron | 43044981 | 43048473 | |
| ENST00000700083 | retained_intron | 43104225 | 43106139 | |
| ENST00000700184 | retained_intron | 43099643 | 43124339 | |
| ENST00000461221 | nonsense_mediated_decay | 43045678 | 43125288 | |
| ENST00000461798 | nonsense_mediated_decay | 43099831 | 43125370 | |
| ENST00000492859 | nonsense_mediated_decay | 43094112 | 43125300 | |
| ENST00000642945 | nonsense_mediated_decay | 43094482 | 43125343 | |
| ENST00000700183 | nonsense_mediated_decay | 43094033 | 43125343 | |
| ENST00000621897 | protein_coding_CDS_not_defined | 43076488 | 43082760 | |
| ENST00000700185 | protein_coding_CDS_not_defined | 43114391 | 43125370 | |
| ENST00000700186 | protein_coding_CDS_not_defined | 43122343 | 43125370 | |
RefSeq Transcripts (mRNA)
Total Count: 100+ transcripts
| Accession | Status | MANE Select |
|---|
| NM_007294 | REVIEWED | ✓ YES |
| NM_001407571 | REVIEWED | |
| NM_001407581 | REVIEWED | |
| NM_001407582 | REVIEWED | |
| NM_001407583 | REVIEWED | |
| NM_001407585 | REVIEWED | |
| NM_001407587 | REVIEWED | |
| NM_001407590 | REVIEWED | |
| NM_001407591 | REVIEWED | |
| NM_001407593 | REVIEWED | |
| ... and 90+ additional transcripts | | |
CCDS IDs
Total Count: 5
| CCDS ID |
|---|
| CCDS11453 |
| CCDS11454 |
| CCDS11455 |
| CCDS11456 |
| CCDS11459 |
Canonical Transcript Exons (ENST00000357654)
Total Exon Count: 23
| Exon ID | Start | End | Strand |
|---|
| ENSE00001852567 | 43125271 | 43125364 | - |
| ENSE00003559512 | 43124017 | 43124115 | - |
| ENSE00003510592 | 43115726 | 43115779 | - |
| ENSE00003531836 | 43104868 | 43104956 | - |
| ENSE00001917948 | 43104122 | 43104261 | - |
| ENSE00004011563 | 43099775 | 43099880 | - |
| ENSE00004011550 | 43097244 | 43097289 | - |
| ENSE00004011559 | 43095846 | 43095922 | - |
| ENSE00004011566 | 43091435 | 43094860 | - |
| ENSE00004011558 | 43090944 | 43091032 | - |
| ENSE00004011560 | 43082404 | 43082575 | - |
| ENSE00004011561 | 43076488 | 43076614 | - |
| ENSE00004011562 | 43074331 | 43074521 | - |
| ENSE00004011554 | 43070928 | 43071238 | - |
| ENSE00004011556 | 43067608 | 43067695 | - |
| ENSE00004011565 | 43063874 | 43063951 | - |
| ENSE00004011567 | 43063333 | 43063373 | - |
| ENSE00004011551 | 43057052 | 43057135 | - |
| ENSE00004011553 | 43051063 | 43051117 | - |
| ENSE00004011568 | 43049121 | 43049194 | - |
| ENSE00004011552 | 43047643 | 43047703 | - |
| ENSE00003541068 | 43106456 | 43106533 | - |
| ENSE00004011564 | 43044295 | 43045802 | - |
Section 3: Protein Identifiers
UniProt Accessions
Total Count: 22 entries
| Accession | Status | Notes |
|---|
| P38398 | Reviewed (Swiss-Prot) | CANONICAL |
| A0A0U1RRA9 | Unreviewed | |
| A0A2R8Y6Y9 | Unreviewed | |
| A0A2R8Y7V5 | Unreviewed | |
| A0A494C182 | Unreviewed | |
| A0A8V8TPY7 | Unreviewed | |
| A0A9Y1QPT7 | Unreviewed | |
| A0A9Y1QQK3 | Unreviewed | |
| C6YB45 | Unreviewed | |
| C9IZW4 | Unreviewed | |
| E7ENB7 | Unreviewed | |
| E7EQW4 | Unreviewed | |
| E7EUM2 | Unreviewed | |
| E7EWN5 | Unreviewed | |
| E9PC22 | Unreviewed | |
| G1UI37 | Unreviewed | |
| H0Y850 | Unreviewed | |
| H0Y8B8 | Unreviewed | |
| H0Y8D8 | Unreviewed | |
| K7EJW3 | Unreviewed | |
| K7EPC7 | Unreviewed | |
| Q3B891 | Unreviewed | |
Canonical Protein (P38398) Properties
| Property | Value |
|---|
| Protein Name | Breast cancer type 1 susceptibility protein |
| Alternative Names | RING finger protein 53; RING-type E3 ubiquitin transferase BRCA1 |
| Length | 1,863 amino acids |
| Molecular Mass | 207,721 Da |
RefSeq Protein Accessions
Total Count: 100+ proteins
| Accession | Status | Notes |
|---|
| NP_009225 | REVIEWED | Corresponds to MANE Select |
| NP_001394500 | REVIEWED | |
| NP_001394510 | REVIEWED | |
| NP_001394511 | REVIEWED | |
| ... and 96+ additional proteins | | |
Protein Domains and Families (InterPro)
Total Count: 9
| InterPro ID | Short Name | Type |
|---|
| IPR001357 | BRCT_dom | Domain |
| IPR001841 | Znf_RING | Domain |
| IPR011364 | BRCA1 | Family |
| IPR013083 | Znf_RING/FYVE/PHD | Homologous_superfamily |
| IPR017907 | Znf_RING_CS | Conserved_site |
| IPR018957 | Znf_C3HC4_RING-type | Domain |
| IPR025994 | BRCA1_serine_dom | Domain |
| IPR031099 | BRCA1-associated | Family |
| IPR036420 | BRCT_dom_sf | Homologous_superfamily |
Section 4: Structure Identifiers
Experimental Structures (PDB)
Total Count: 33 structures
| PDB ID | Title | Method | Resolution |
|---|
| 1JM7 | BRCA1/BARD1 RING-domain heterodimer | NMR | - |
| 1JNX | BRCT repeat region | X-ray | 2.5 Å |
| 1N5O | BRCA1-BRCT missense mutation | X-ray | 2.8 Å |
| 1OQA | BRCT-c domain | NMR | - |
| 1T15 | BRCT + BACH1 phosphopeptide | X-ray | 1.85 Å |
| 1T29 | BRCT + phospho-BACH1 | X-ray | 2.3 Å |
| 1T2U | BRCT V1809F variant | X-ray | 2.8 Å |
| 1T2V | BRCT + phosphopeptide | X-ray | 3.3 Å |
| 1Y98 | BRCT + CtIP phosphopeptide | X-ray | 2.5 Å |
| 2ING | BRCT M1775K variant | X-ray | 3.6 Å |
| 3COJ | BRCT + ACC1 phosphopeptide | X-ray | 3.21 Å |
| 3K0H | BRCT + minimal tetrapeptide | X-ray | 2.7 Å |
| 3K0K | BRCT + tetrapeptide | X-ray | 2.7 Å |
| 3K15 | BRCT D1840T + tetrapeptide | X-ray | 2.8 Å |
| 3K16 | BRCT D1840T + tetrapeptide | X-ray | 3.0 Å |
| 3PXA | BRCT G1656D variant | X-ray | 2.55 Å |
| 3PXB | BRCT T1700A variant | X-ray | 2.5 Å |
| 3PXC | BRCT R1699Q variant | X-ray | 2.8 Å |
| 3PXD | BRCT R1835P variant | X-ray | 2.8 Å |
| 3PXE | BRCT E1836K variant | X-ray | 2.85 Å |
| 4IFI | BRCT + BAAT peptide | X-ray | 2.2 Å |
| 4IGK | BRCT + ATRIP peptide | X-ray | 1.75 Å |
| 4JLU | BRCT + phospho-Abraxas | X-ray | 3.5 Å |
| 4OFB | BRCT + nonphosphopeptide inhibitor | X-ray | 3.05 Å |
| 4U4A | BRCT + singly phospho-Abraxas | X-ray | 3.51 Å |
| 4Y18 | BRCT + double phospho-Abraxas | X-ray | 3.5 Å |
| 4Y2G | BRCT + single phospho-Abraxas | X-ray | 2.5 Å |
| 6G2I | ACC + BRCT filament | Cryo-EM | 5.9 Å |
| 7JZV | BRCA1-UbcH5c/BARD1 + nucleosome | Cryo-EM | 3.9 Å |
| 7LYB | Nucleosome + BRCA1-BARD1-UbcH5c | Cryo-EM | 3.28 Å |
| 8GRQ | BRCA1/BARD1 + ubiquitinated nucleosome | Cryo-EM | 3.87 Å |
| 8RS8 | BRCT + RIF1 phosphopeptide | X-ray | 1.31 Å |
| 9QPX | BRCT + RNA Pol II CTD peptide | X-ray | 3.0 Å |
Predicted Structures (AlphaFold)
| AlphaFold ID | Global pLDDT | Sequence Length | Very High Confidence (%) |
|---|
| AF-P38398-F1 | 41.99 | 14,550 | 11% |
Section 5: Cross-Species Orthologs
| Organism | Gene ID | Symbol | Biotype |
|---|
| Mouse (Mus musculus) | ENSMUSG00000017146 | Brca1 | protein_coding |
| Rat (Rattus norvegicus) | ENSRNOG00000020701 | Brca1 | protein_coding |
| C. elegans | WBGENE00000264 | brc-1 | - |
| C. elegans | WBGENE00018327 | - | - |
| Zebrafish (Danio rerio) | No direct ortholog | - | - |
| Fruit fly (Drosophila) | No direct ortholog | - | - |
| Yeast (S. cerevisiae) | No ortholog | - | - |
Section 6: Clinical Variants & AI Predictions
ClinVar Summary
Total Variant Count: 15,445
| Classification | Status |
|---|
| Pathogenic | ~2,500+ |
| Likely Pathogenic | ~500+ |
| Uncertain Significance (VUS) | ~8,000+ |
| Likely Benign | ~1,500+ |
| Benign | ~2,000+ |
| Conflicting | ~1,000+ |
TOP 50 Pathogenic/Likely Pathogenic Variants (ClinVar)
| Variant ID | HGVS | Type |
|---|
| 1012155 | c.1728del (p.Glu577fs) | Deletion |
| 1012156 | c.3982del (p.Ser1328fs) | Deletion |
| 1049053 | c.5296del (p.Ile1766fs) | Deletion |
| 1049103 | c.5141_5144del (p.Val1714fs) | Deletion |
| 1049239 | c.1100del (p.Thr367fs) | Deletion |
| 1049275 | c.5280del (p.Phe1761fs) | Deletion |
| 1049277 | c.3914dup (p.Asp1305fs) | Duplication |
| 1049514 | c.2827A>T (p.Lys943Ter) | Nonsense |
| 1049719 | c.851del (p.Gln284fs) | Deletion |
| 1049776 | c.1603G>T (p.Gly535Ter) | Nonsense |
| 1049828 | c.1848_1861del (p.Thr617fs) | Deletion |
| 1049895 | c.2365del (p.Ser789fs) | Deletion |
| 1050145 | c.66_67delinsTT (p.Leu22_Glu23delinsPheTer) | Indel |
| 1050371 | c.709G>T (p.Glu237Ter) | Nonsense |
| 1050671 | c.3476del (p.Ile1159fs) | Deletion |
| 1050776 | c.3225_3226del (p.Asn1075fs) | Deletion |
| 1068565 | c.2479_2480del (p.Glu827fs) | Deletion |
| 1069423 | c.1997_1998del (p.Leu666fs) | Deletion |
| 1070111 | c.3975del (p.Arg1325fs) | Deletion |
| 1070603 | c.2163del (p.Phe721fs) | Deletion |
| 1070907 | c.5202dup (p.Glu1735Ter) | Duplication |
| 1070948 | c.4799del (p.Ala1599_Leu1600insTer) | Deletion |
| 1071122 | c.3257_3258insTTGC (p.Leu1086fs) | Insertion |
| 1071268 | c.2145_2152del (p.Thr715_Ser716insTer) | Deletion |
| 1071282 | c.3381T>A (p.Tyr1127Ter) | Nonsense |
| 1071926 | c.4583_4589dup (p.Lys1530delinsAsnHisTer) | Duplication |
| 1071944 | c.4463_4467dup (p.Glu1490fs) | Duplication |
| 1072656 | c.2899dup (p.Thr967fs) | Duplication |
| 1072718 | c.292_293insT (p.Gly98fs) | Insertion |
| 1072912 | c.4862_4863insG (p.Asp1621fs) | Insertion |
| 1073201 | c.133_134+1del | Splice |
| 1073249 | c.4513del (p.Asp1505fs) | Deletion |
| 1073509 | c.671-8_671-2del | Splice |
| 1073669 | c.3679del (p.Gln1227fs) | Deletion |
| 1073703 | c.1099del (p.Thr367fs) | Deletion |
| 1074343 | c.1423_1508del (p.Ser475fs) | Deletion |
| 1074407 | c.2635del (p.Glu879fs) | Deletion |
| 1074646 | c.1709del (p.Pro570fs) | Deletion |
| 1074684 | c.1009G>T (p.Glu337Ter) | Nonsense |
| 1074746 | c.2735_2738del (p.Lys912fs) | Deletion |
| 1074750 | c.1682del (p.Ser561fs) | Deletion |
| 1074789 | c.4544_4545dup (p.Ser1516fs) | Duplication |
| 1075200 | c.959_981del (p.Arg320fs) | Deletion |
| ... and many more large deletions/duplications | | |
SpliceAI Predictions
Total Count: 3,719
TOP 50 Splice-Altering Variants (Δ Score ≥ 0.9)
| Variant | Effect | Δ Score |
|---|
| 17:43045800:TTG:T | acceptor_gain | 1.00 |
| 17:43045801:TGCTG:T | acceptor_loss | 1.00 |
| 17:43045798:AATTG:A | acceptor_gain | 0.99 |
| 17:43045799:ATTG:A | acceptor_gain | 0.99 |
| 17:43045801:TG:T | acceptor_gain | 0.99 |
| 17:43045803:C:CC | acceptor_gain | 0.99 |
| 17:43045810:C:CT | acceptor_gain | 0.98 |
| 17:43045811:A:T | acceptor_gain | 0.98 |
| 17:43045797:CAAT:C | acceptor_gain | 0.95 |
| 17:43047636:ACCTT:A | donor_loss | 0.95 |
| 17:43047637:CCTTA:C | donor_loss | 0.95 |
| 17:43047638:CTTAC:C | donor_loss | 0.95 |
| 17:43047639:TTA:T | donor_loss | 0.95 |
| 17:43047640:TACCA:T | donor_loss | 0.95 |
| 17:43047641:ACC:A | donor_loss | 0.95 |
| 17:43045799:ATTGC:A | acceptor_gain | 0.97 |
| 17:43045800:TTGC:T | acceptor_gain | 0.97 |
| 17:43045801:TGCT:T | acceptor_gain | 0.97 |
| 17:43045802:GCTG:G | acceptor_gain | 0.97 |
| 17:43045804:T:G | acceptor_gain | 0.97 |
| 17:43045803:CTGG:C | acceptor_gain | 0.96 |
| 17:43047635:CACCT:C | donor_loss | 0.92 |
| 17:43045800:T:C | acceptor_gain | 0.92 |
| 17:43045796:CCAAT:C | acceptor_gain | 0.91 |
| 17:43047641:A:AC | donor_gain | 0.90 |
| 17:43047642:C:CC | donor_gain | 0.90 |
| ... and many more | | |
AlphaMissense Predictions
Total Count: 12,463
TOP 50 Predicted Pathogenic Missense Variants (Score ≥ 0.9)
| Variant | Protein Change | AM Score | Classification |
|---|
| 17:43045713:A:C | Y1853D | 0.940 | likely_pathogenic |
| 17:43045747:A:C | S1841R | 0.996 | likely_pathogenic |
| 17:43045747:A:T | S1841R | 0.996 | likely_pathogenic |
| 17:43045749:T:G | S1841R | 0.996 | likely_pathogenic |
| 17:43047684:A:T | V1809D | 0.993 | likely_pathogenic |
| 17:43045759:C:A | W1837C | 0.990 | likely_pathogenic |
| 17:43045759:C:G | W1837C | 0.990 | likely_pathogenic |
| 17:43045751:T:A | D1840V | 0.982 | likely_pathogenic |
| 17:43045761:A:G | W1837R | 0.998 | likely_pathogenic |
| 17:43045761:A:T | W1837R | 0.998 | likely_pathogenic |
| 17:43045760:C:G | W1837S | 0.980 | likely_pathogenic |
| 17:43045752:C:G | D1840H | 0.978 | likely_pathogenic |
| 17:43045772:A:T | V1833E | 0.983 | likely_pathogenic |
| 17:43045757:A:T | V1838E | 0.971 | likely_pathogenic |
| 17:43045766:C:G | R1835P | 0.969 | likely_pathogenic |
| 17:43045751:T:G | D1840A | 0.966 | likely_pathogenic |
| 17:43045743:C:G | A1843P | 0.964 | likely_pathogenic |
| 17:43045742:G:T | A1843E | 0.961 | likely_pathogenic |
| 17:43045751:T:C | D1840G | 0.958 | likely_pathogenic |
| 17:43045745:A:T | V1842E | 0.956 | likely_pathogenic |
| 17:43047687:A:T | V1808E | 0.955 | likely_pathogenic |
| 17:43045750:G:C | D1840E | 0.954 | likely_pathogenic |
| 17:43045750:G:T | D1840E | 0.954 | likely_pathogenic |
| 17:43045748:C:A | S1841I | 0.954 | likely_pathogenic |
| 17:43045752:C:A | D1840Y | 0.948 | likely_pathogenic |
| 17:43045754:A:G | L1839S | 0.941 | likely_pathogenic |
| 17:43045737:A:C | Y1845D | 0.918 | likely_pathogenic |
| 17:43045760:C:A | W1837L | 0.914 | likely_pathogenic |
| 17:43047678:T:G | Q1811P | 0.914 | likely_pathogenic |
| 17:43045763:T:A | E1836V | 0.910 | likely_pathogenic |
| 17:43045761:A:C | W1837G | 0.909 | likely_pathogenic |
| 17:43045748:C:T | S1841N | 0.907 | likely_pathogenic |
| 17:43047677:C:A | Q1811H | 0.903 | likely_pathogenic |
| 17:43047677:C:G | Q1811H | 0.903 | likely_pathogenic |
| 17:43045739:A:G | L1844P | 0.896 | likely_pathogenic |
| 17:43045764:C:T | E1836K | 0.894 | likely_pathogenic |
| 17:43045752:C:T | D1840N | 0.881 | likely_pathogenic |
| 17:43047670:C:G | A1814P | 0.870 | likely_pathogenic |
| 17:43045713:A:G | Y1853H | 0.867 | likely_pathogenic |
| 17:43045709:A:G | L1854P | 0.867 | likely_pathogenic |
| 17:43047667:A:G | W1815R | 0.865 | likely_pathogenic |
| 17:43047667:A:T | W1815R | 0.865 | likely_pathogenic |
| 17:43045745:A:C | V1842G | 0.866 | likely_pathogenic |
| 17:43045713:A:T | Y1853N | 0.858 | likely_pathogenic |
| 17:43045754:A:C | L1839W | 0.850 | likely_pathogenic |
| 17:43047681:A:T | V1810E | 0.848 | likely_pathogenic |
| 17:43047678:T:C | Q1811R | 0.843 | likely_pathogenic |
| 17:43045767:G:C | R1835G | 0.837 | likely_pathogenic |
| 17:43047685:C:A | V1809F | 0.834 | likely_pathogenic |
| 17:43045712:T:G | Y1853S | 0.832 | likely_pathogenic |
Section 7: Biological Pathways & Gene Ontology
Reactome Pathways
Total Count: 27 pathways (7 disease pathways)
| Pathway ID | Name | Disease? |
|---|
| R-HSA-5685942 | HDR through Homologous Recombination (HRR) | No |
| R-HSA-5685938 | HDR through Single Strand Annealing (SSA) | No |
| R-HSA-5693607 | Processing of DNA double-strand break ends | No |
| R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation at DSBs | No |
| R-HSA-5693579 | Homologous DNA Pairing and Strand Exchange | No |
| R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | No |
| R-HSA-5693616 | Presynaptic phase of homologous DNA pairing | No |
| R-HSA-5693554 | Resolution of D-loop Structures through SDSA | No |
| R-HSA-5693568 | Resolution of D-loop through Holliday Junction | No |
| R-HSA-69473 | G2/M DNA damage checkpoint | No |
| R-HSA-912446 | Meiotic recombination | No |
| R-HSA-1221632 | Meiotic synapsis | No |
| R-HSA-3108214 | SUMOylation of DNA damage response proteins | No |
| R-HSA-5689901 | Metalloprotease DUBs | No |
| R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | No |
| R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | No |
| R-HSA-8951664 | Neddylation | No |
| R-HSA-8953750 | Transcriptional Regulation by E2F6 | No |
| R-HSA-9755511 | KEAP1-NFE2L2 pathway | No |
| R-HSA-9825895 | Regulation of MITF-M-dependent genes | No |
| R-HSA-9663199 | Defective DNA DSB response due to BRCA1 loss | Yes |
| R-HSA-9699150 | Defective DNA DSB response due to BARD1 loss | Yes |
| R-HSA-9701192 | Defective HRR due to BRCA1 loss of function | Yes |
| R-HSA-9704331 | Defective HRR due to PALB2 loss of BRCA1 binding | Yes |
| R-HSA-9704646 | Defective HRR due to PALB2 loss of BRCA2/RAD51 binding | Yes |
| R-HSA-9709570 | Impaired BRCA2 binding to RAD51 | Yes |
| R-HSA-9709603 | Impaired BRCA2 binding to PALB2 | Yes |
Gene Ontology Annotations
Total Count: 77 GO terms
Biological Process (37 terms)
| GO ID | Term |
|---|
| GO:0000724 | double-strand break repair via homologous recombination |
| GO:0006281 | DNA repair |
| GO:0006282 | regulation of DNA repair |
| GO:0006301 | DNA damage tolerance |
| GO:0006302 | double-strand break repair |
| GO:0006338 | chromatin remodeling |
| GO:0006357 | regulation of transcription by RNA polymerase II |
| GO:0006633 | fatty acid biosynthetic process |
| GO:0006974 | DNA damage response |
| GO:0007059 | chromosome segregation |
| GO:0007095 | mitotic G2 DNA damage checkpoint signaling |
| GO:0007098 | centrosome cycle |
| GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0010212 | response to ionizing radiation |
| GO:0010575 | positive regulation of VEGF production |
| GO:0010628 | positive regulation of gene expression |
| GO:0016567 | protein ubiquitination |
| GO:0030308 | negative regulation of cell growth |
| GO:0033147 | negative regulation of intracellular estrogen receptor signaling |
| GO:0035825 | homologous recombination |
| GO:0043009 | chordate embryonic development |
| GO:0044027 | negative regulation via chromosomal CpG island methylation |
| GO:0044818 | mitotic G2/M transition checkpoint |
| GO:0045717 | negative regulation of fatty acid biosynthetic process |
| GO:0045739 | positive regulation of DNA repair |
| GO:0045766 | positive regulation of angiogenesis |
| GO:0045786 | negative regulation of cell cycle |
| GO:0045892 | negative regulation of DNA-templated transcription |
| GO:0045893 | positive regulation of DNA-templated transcription |
| GO:0045944 | positive regulation of transcription by RNA polymerase II |
| GO:0046600 | negative regulation of centriole replication |
| GO:0051726 | regulation of cell cycle |
| GO:0051865 | protein autoubiquitination |
| GO:0060816 | random inactivation of X chromosome |
| GO:0071356 | cellular response to tumor necrosis factor |
| GO:0071479 | cellular response to ionizing radiation |
| GO:0071681 | cellular response to indole-3-methanol |
Molecular Function (17 terms)
| GO ID | Term |
|---|
| GO:0000976 | transcription cis-regulatory region binding |
| GO:0002039 | p53 binding |
| GO:0003677 | DNA binding |
| GO:0003684 | damaged DNA binding |
| GO:0003713 | transcription coactivator activity |
| GO:0003723 | RNA binding |
| GO:0004842 | ubiquitin-protein transferase activity |
| GO:0008270 | zinc ion binding |
| GO:0015631 | tubulin binding |
| GO:0019899 | enzyme binding |
| GO:0031625 | ubiquitin protein ligase binding |
| GO:0042802 | identical protein binding |
| GO:0061649 | ubiquitin-modified histone reader activity |
| GO:0070063 | RNA polymerase binding |
| GO:0140863 | histone H2AK127 ubiquitin ligase activity |
| GO:0140864 | histone H2AK129 ubiquitin ligase activity |
| GO:0085020 | protein K6-linked ubiquitination |
Cellular Component (23 terms)
| GO ID | Term |
|---|
| GO:0000151 | ubiquitin ligase complex |
| GO:0000152 | nuclear ubiquitin ligase complex |
| GO:0000800 | lateral element |
| GO:0000931 | gamma-tubulin ring complex |
| GO:0001673 | male germ cell nucleus |
| GO:0001741 | XY body |
| GO:0005634 | nucleus |
| GO:0005654 | nucleoplasm |
| GO:0005694 | chromosome |
| GO:0005737 | cytoplasm |
| GO:0005886 | plasma membrane |
| GO:0016604 | nuclear body |
| GO:0031436 | BRCA1-BARD1 complex |
| GO:0032991 | protein-containing complex |
| GO:0070531 | BRCA1-A complex |
| GO:0070532 | BRCA1-B complex |
| GO:0070533 | BRCA1-C complex |
| GO:1990391 | DNA repair complex |
| GO:1990904 | ribonucleoprotein complex |
Section 8: Protein Interactions & Molecular Networks
STRING Interactions
Total Count: 6,120+ interactions
TOP 50 Highest-Confidence Interactors (Score ≥ 900)
| UniProt B | Gene | Score |
|---|
| P38398 | BRCA1 (self) | 999 |
| P51587 | BRCA2 | 999 |
| Q06609 | RAD51 | 999 |
| Q12888 | TP53BP1 | 999 |
| Q13315 | ATM | 999 |
| Q86YC2 | PALB2 | 999 |
| P04637 | TP53 | 999 |
| Q99728 | BARD1 | 993 |
| Q99708 | RBBP8 | 998 |
| Q9BXW9 | FANCD2 | 998 |
| O96017 | CHEK2 | 997 |
| Q6UWZ7 | ABRAXAS1 | 997 |
| Q96RL1 | UIMC1/RAP80 | 997 |
| Q9BX63 | BRCC3 | 997 |
| Q14676 | MDC1 | 996 |
| P01106 | MYC | 995 |
| P03372 | ESR1 | 995 |
| P46736 | BRCC36 | 995 |
| Q7Z569 | BRAP | 995 |
| Q9NXR7 | BABAM2 | 995 |
| Q9GZX5 | MRE11 | 994 |
| Q92560 | USP7 | 987 |
| P16104 | H2AFX | 983 |
| O15360 | FANCA | 978 |
| P52701 | MSH6 | 978 |
| P49959 | MRE11 | 974 |
| Q08211 | DHX9 | 967 |
| O14757 | CHEK1 | 965 |
| Q7Z333 | SETX | 962 |
| P43351 | BTRC | 961 |
| P51532 | SMARCA4 | 957 |
| O43502 | RFWD3 | 954 |
| Q9NVI1 | FANCI | 952 |
| Q05048 | CSTF1 | 948 |
| P43246 | MSH2 | 947 |
| P42224 | STAT1 | 943 |
| Q9NRR4 | NOP10 | 940 |
| P09874 | PARP1 | 936 |
| O76064 | RIFL1 | 931 |
| P40692 | MLH1 | 930 |
| P06401 | PGR | 929 |
| Q09472 | EP300 | 928 |
| Q8IYW5 | RNF138 | 921 |
| P04626 | ERBB2 | 919 |
| Q13547 | HDAC1 | 918 |
| O75330 | HMMR | 912 |
| A0A087WY85 | RAD51B | 912 |
| P30304 | CDC25A | 911 |
| O43542 | XRCC3 | 909 |
| O75771 | RAD51C | 904 |
IntAct Interactions
Total Count: 342+ curated interactions
Key High-Confidence Direct Interactions
| Partner Gene | Interaction Type | Confidence |
|---|
| BRIP1 (BACH1) | direct interaction | 0.98 |
| BARD1 | physical association | 0.96 |
| RBBP8 (CtIP) | physical association | 0.93 |
| PALB2 | physical association | 0.91 |
| ABRAXAS1 | direct interaction | 0.86 |
| ESR1 | direct interaction | 0.81 |
| UIMC1 (RAP80) | direct interaction | 0.78 |
| BRCA2 | association | 0.73 |
| H2AFX | colocalization | 0.71 |
| TP53BP1 | physical association | 0.70 |
| RPA1 | physical association | 0.65 |
| MDC1 | physical association | 0.63 |
| BRCC3 | association | 0.61 |
| BRAT1 | physical association | 0.60 |
| SUMO1 | physical association | 0.60 |
| PPP1CB | physical association | 0.58 |
| TOP2A | physical association | 0.52 |
| ACACA | physical association | 0.52 |
BioGRID Interactions
Total Count: 2,598+ interactions
Protein Similarity
ESM2 Structural/Embedding Similarity
Total Similar Proteins: 52
| UniProt ID | Top Similarity | Avg Similarity |
|---|
| Q6J6I8 | 1.0000 | 0.9929 |
| Q9GKK8 | 1.0000 | 0.9931 |
| G7NY55 | 0.9999 | 0.9933 |
| F6ULY3 | 0.9999 | 0.9932 |
| G3S077 | 0.9998 | 0.9935 |
| Q8N9V7 | 0.9998 | 0.9931 |
| P97929 | 0.9995 | 0.9927 |
| O35923 | 0.9995 | 0.9921 |
| P51587 (BRCA2) | 0.9994 | 0.9914 |
| Q00756 | 0.9993 | 0.9876 |
| F7DF15 | 0.9993 | 0.9933 |
| D3ZUC6 | 0.9992 | 0.9927 |
| E5FYH1 | 0.9992 | 0.9927 |
| Q95153 | 0.9990 | 0.9932 |
| G7H7V7 | 0.9988 | 0.9932 |
| E5FYH0 | 0.9985 | 0.9930 |
| Q66JQ7 | 0.9985 | 0.9852 |
| Q99MR9 | 0.9984 | 0.9877 |
| Q6NZG4 | 0.9984 | 0.9876 |
| Q8IXT1 | 0.9984 | 0.9869 |
DIAMOND Sequence Similarity
Total Homologous Proteins: 96
| UniProt ID | Identity (%) | Bitscore |
|---|
| Q6J6I8 | 98.8 | 3520 |
| Q9GKK8 | 98.8 | 3515 |
| P38398 (self) | 98.5 | 3486 |
| Q6J6J0 | 97.5 | 3448 |
| Q6J6I9 | 93.6 | 3310 |
| O54952 | 81.0 | 2758 |
| P48754 | 81.0 | 2752 |
| Q95153 | 74.4 | 2524 |
| Q864U1 | 71.4 | 2368 |
| Q14527 | 91.1 | 1806 |
| Q95216 | 91.1 | 1804 |
| Q6PCN7 | 83.6 | 1652 |
| Q8HXH0 | 92.6 | 1357 |
| Q496Y0 | 92.6 | 1356 |
| D3YY23 | 87.8 | 1325 |
| Q17RB8 | 87.8 | 1326 |
| Q9D4H7 | 79.5 | 1149 |
| P43254 | 76.1 | 1017 |
| Q3MV19 | 87.7 | 1015 |
| Q6DJN2 | 87.7 | 1016 |
Section 9: Transcription Factor Regulatory Data
BRCA1 as a Transcription Factor/Co-regulator
Total Regulatory Connections: 140
Downstream Targets (Genes Regulated BY BRCA1)
Count: 60+ targets
| Target Gene | Regulation | Confidence |
|---|
| AREG | Repression | - |
| ASPM | Activation | - |
| ATM | Activation | - |
| BARD1 | Repression | High |
| BRCA1 | Repression (autoregulation) | High |
| BRCA2 | Unknown | - |
| CASR | Unknown | - |
| CCNB1 | Unknown | - |
| CCND1 | Unknown | - |
| CDH3 | Repression | - |
| CDKN1A (p21) | Activation | - |
| CDKN1B (p27) | Activation | - |
| CTSD | Repression | - |
| CXCL1 | Repression | - |
| CYP19A1 | Activation | High |
| CYP1A1 | Unknown | High |
| CYP1B1 | Unknown | High |
| DDB2 | Activation | - |
| DDIT3 | Activation | - |
| E2F6 | Repression | - |
| EGFR | Repression | - |
| EGR1 | Unknown | - |
| EP300 | Activation | - |
| ESR1 | Activation | - |
| FOS | Unknown | - |
| FOXC1 | Repression | - |
| FOXC2 | Repression | - |
| FST | Activation | - |
| GADD45A | Activation | - |
| HIF1A | Unknown | - |
| HMGA2 | Repression | - |
| HNRNPA2B1 | Repression | - |
| HSPA5 | Repression | - |
| IFNA1 | Activation | - |
| IGF1 | Repression | - |
| IRF7 | Activation | - |
| IRF9 | Activation | - |
| MAD2L1 | Activation | - |
| MDM2 | Activation | - |
| MYC | Unknown | - |
| NOS3 | Activation | - |
| NTHL1 | Activation | - |
| RNASEL | Activation | - |
| S100A2 | Activation | - |
| SIRT1 | Activation | - |
| STAT1 | Activation | - |
| STAT2 | Activation | - |
| TFF1 | Repression | - |
| VEGFA | Activation | - |
| XPC | Unknown | - |
Upstream Regulators (TFs that Regulate BRCA1)
Count: 80+ regulators
| Regulator | Regulation | Confidence |
|---|
| AHR | Unknown | High |
| AP1 | Activation | Low |
| APEX1 | - | High |
| ARNT | Unknown | - |
| BHLHE41 | Repression | Low |
| CHD8 | Unknown | - |
| CREB1 | Unknown | High |
| CREBBP | Unknown | - |
| CTBP1 | Repression | - |
| CTBP2 | Repression | High |
| CTCF | Unknown | High |
| DLX4 | Repression | High |
| DNMT1 | - | High |
| E2F1 | Repression | High |
| E2F2 | - | High |
| E2F3 | - | High |
| E2F4 | Activation | High |
| E2F5 | - | High |
| E2F6 | Unknown | High |
| EGR1 | Unknown | High |
| EP300 | Activation | - |
| ESR1 | Unknown | High |
| ETS2 | Repression | High |
| EZH2 | Unknown | Low |
| FOS | Activation | Low |
| FOSL2 | Activation | - |
| FOXA1 | Unknown | High |
| FOXP3 | Repression | High |
| GABPA | Activation | High |
| HIF1A | Repression | Low |
| HMGA1 | Repression | High |
SIGNOR Signaling Interactions
Total Count: 83 interactions
Key upstream kinases/regulators:
| - ATM | - ATR | - CHEK2 | - CDK1 | - CDK2 | - AKT1 | - AURKA | - PPP1CA |
|---|
| phosphorylates BRCA1 (multiple sites) | phosphorylates BRCA1 | phosphorylates BRCA1 at S988 | phosphorylates BRCA1 | phosphorylates BRCA1 | phosphorylates BRCA1 | phosphorylates BRCA1 | dephosphorylates BRCA1 | |
| | | | | | | | Drug & Pharmacology Data** |
ChEMBL Target
| Property | Value |
|---|
| ChEMBL Target ID | CHEMBL5990 |
| Target Type | SINGLE PROTEIN |
| Total Activities | 358 |
| Total Molecules | 310 |
Molecules Targeting BRCA1
Total Count: 310 molecules
Notable Compounds
| ChEMBL ID | Name | Type | Phase |
|---|
| CHEMBL140 | CURCUMIN | Small molecule | 3 |
| CHEMBL102714 | SB-216763 | Small molecule | 0 |
| CHEMBL129177 | HARMALOL | Small molecule | 0 |
| + 307 additional compounds | | | |
PharmGKB Gene Status
| Property | Value |
|---|
| PharmGKB ID | PA25411 |
| VIP Gene | Yes |
| Has Variant Annotation | Yes |
| Has CPIC Guideline | No |
Drug-Gene Associations (PharmGKB)
| Drug | PharmGKB ID | Clinical Annotations |
|---|
| Olaparib | PA164920420 | 0 |
| Niraparib | PA166131610 | 0 |
| Rucaparib | PA166163418 | 0 |
| Talazoparib | PA166182740 | 0 |
| Sacituzumab govitecan | PA166225061 | 1 |
| Note |
|---|
| BRCA1/2 mutations are biomarkers for PARP inhibitor therapy (olaparib, niraparib, rucaparib, talazoparib) in breast and ovarian cancers. | |
| Expression Profiles** |
Bgee Expression Summary
| Property | Value |
|---|
| Expression Breadth | Ubiquitous |
| Total Present Calls | 208 |
| Total Absent Calls | 58 |
| Total Conditions | 266 |
| Max Expression Score | 90.68 |
| Average Expression Score | 68.16 |
| Gold Quality Count | 225 |
TOP 30 Tissues by Expression Score
| Tissue/Anatomical Entity | Expression | Score | Quality |
|---|
| Ventricular zone | present | 90.68 | gold |
| Male germ line stem cell in testis | present | 89.54 | gold |
| Primordial germ cell in gonad | present | 86.44 | gold |
| Ganglionic eminence | present | 86.30 | gold |
| Embryo | present | 85.26 | gold |
| Secondary oocyte | present | 84.10 | gold |
| Bone marrow cell | present | 82.00 | gold |
| Oocyte | present | 81.87 | gold |
| Endometrium epithelium | present | 81.67 | gold |
| Sural nerve | present | 81.55 | gold |
| Trabecular bone tissue | present | 80.40 | gold |
| Stromal cell of endometrium | present | 79.88 | gold |
| Colonic epithelium | present | 79.56 | gold |
| Bone marrow | present | 79.55 | gold |
| Testis | present | 78.58 | gold |
| Right testis | present | 78.11 | gold |
| Rectum | present | 78.05 | gold |
| Left testis | present | 77.69 | gold |
| Right lobe of thyroid gland | present | 77.35 | gold |
| Vermiform appendix | present | 77.10 | gold |
| Tonsil | present | 76.23 | gold |
| Left lobe of thyroid gland | present | 75.58 | gold |
| Hindlimb stylopod muscle | present | 74.97 | gold |
| Thyroid gland | present | 74.62 | gold |
| Mucosa of transverse colon | present | 74.61 | gold |
| Adrenal tissue | present | 74.41 | gold |
| Choroid plexus epithelium | present | 74.34 | silver |
| Calcaneal tendon | present | 73.96 | gold |
| Lymph node | present | 73.91 | gold |
Single-Cell Expression Data
| Dataset ID | Description | Species | Cells |
|---|
| E-GEOD-99795 | LNCaP prostate carcinoma cells ± androgen | Homo sapiens | 144 |
Section 12: Disease Associations
OMIM Disease Associations
| OMIM ID | Disease |
|---|
| 113705 | BRCA1 gene locus |
| 604370 | Breast-ovarian cancer, familial, susceptibility to, 1 |
| 617883 | Fanconi anemia, complementation group S |
| 614320 | Pancreatic cancer, susceptibility to, 4 |
| 167000 | Ovarian cancer |
| 114480 | Breast cancer |
GenCC Gene-Disease Classifications
| Disease | Classification | Inheritance | Submitter |
|---|
| Breast-ovarian cancer, familial, susceptibility to, 1 (OMIM:604370) | Definitive | Autosomal dominant | Ambry Genetics |
| Breast-ovarian cancer, familial, susceptibility to, 1 (OMIM:604370) | Strong | Autosomal dominant | Genomics England PanelApp |
| Breast-ovarian cancer, familial, susceptibility to, 1 (OMIM:604370) | Strong | Autosomal dominant | Labcorp Genetics |
| Fanconi anemia, complementation group S (OMIM:617883) | Strong | Autosomal recessive | G2P |
| Fanconi anemia, complementation group S (OMIM:617883) | Moderate | Autosomal recessive | Ambry Genetics |
| Fanconi anemia, complementation group S (OMIM:617883) | Limited | Autosomal recessive | Labcorp Genetics |
| Pancreatic cancer, susceptibility to, 4 (OMIM:614320) | Moderate | Autosomal dominant | Genomics England PanelApp |
| Hereditary breast ovarian cancer syndrome (ORPHA:145) | Supportive | Autosomal dominant | Orphanet |
| Fanconi anemia (ORPHA:84) | Supportive | Autosomal recessive | Orphanet |
Orphanet Disease Associations
Total Count: 9 diseases
| Orphanet ID | Disease | Type | Gene Count |
|---|
| ORPHA:145 | Hereditary breast and/or ovarian cancer syndrome | Disease | 15 |
| ORPHA:84 | Fanconi anemia | Malformation syndrome | 23 |
| ORPHA:227535 | Hereditary breast cancer | Disease | 10 |
| ORPHA:1333 | Familial pancreatic carcinoma | Disease | 9 |
| ORPHA:1331 | Familial prostate cancer | Disease | 15 |
| ORPHA:168829 | Primary peritoneal carcinoma | Disease | 1 |
| ORPHA:667662 | Breast implant-associated anaplastic large cell lymphoma | Disease | 7 |
| ORPHA:694963 | Inflammatory breast cancer | Disease | 2 |
| ORPHA:70567 | Cholangiocarcinoma | Disease | 4 |
HPO Phenotype Associations
Total Count: 166 phenotypes
TOP 50 Clinical Phenotypes
| HPO ID | Phenotype |
|---|
| HP:0000006 | Autosomal dominant inheritance |
| HP:0000007 | Autosomal recessive inheritance |
| HP:0001249 | Intellectual disability |
| HP:0001263 | Global developmental delay |
| HP:0001510 | Growth delay |
| HP:0001511 | Intrauterine growth retardation |
| HP:0001508 | Failure to thrive |
| HP:0000252 | Microcephaly |
| HP:0000365 | Hearing impairment |
| HP:0000518 | Cataract |
| HP:0001873 | Thrombocytopenia |
| HP:0001903 | Anemia |
| HP:0001882 | Decreased total leukocyte count |
| HP:0000027 | Azoospermia |
| HP:0000028 | Cryptorchidism |
| HP:0000135 | Hypogonadism |
| HP:0000130 | Abnormality of the uterus |
| HP:0000813 | Bicornuate uterus |
| HP:0000175 | Cleft palate |
| HP:0000218 | High palate |
| HP:0000347 | Micrognathia |
| HP:0000316 | Hypertelorism |
| HP:0000486 | Strabismus |
| HP:0000568 | Microphthalmia |
| HP:0001631 | Atrial septal defect |
| HP:0001643 | Patent ductus arteriosus |
| HP:0001639 | Hypertrophic cardiomyopathy |
| HP:0002023 | Anal atresia |
| HP:0000453 | Choanal atresia |
| HP:0001172 | Abnormal thumb morphology |
| HP:0001199 | Triphalangeal thumb |
| HP:0001392 | Abnormality of the liver |
| HP:0001738 | Exocrine pancreatic insufficiency |
| HP:0000079 | Abnormality of the urinary system |
| HP:0000083 | Renal insufficiency |
| HP:0001537 | Umbilical hernia |
| HP:0002007 | Frontal bossing |
| HP:0000340 | Sloping forehead |
| HP:0000280 | Coarse facial features |
| HP:0000989 | Pruritus |
| HP:0001000 | Abnormality of skin pigmentation |
| HP:0001053 | Hypopigmented skin patches |
| HP:0001945 | Fever |
| HP:0001824 | Weight loss |
| HP:0002039 | Anorexia |
| HP:0002017 | Nausea and vomiting |
| HP:0002027 | Abdominal pain |
| HP:0002019 | Constipation |
| HP:0002254 | Intermittent diarrhea |
| HP:0001251 | Ataxia |
GWAS Associations
Total Count: 7
| Study ID | Trait | P-value |
|---|
| GCST90011899_184 | Aspartate aminotransferase levels | 1.0e-12 |
| GCST005312_44 | Menopause (age at onset) | 8.0e-11 |
| GCST90002394_251 | Monocyte percentage of white cells | 1.0e-10 |
| GCST005863_3 | Menopause (age at onset) | 1.0e-08 |
| GCST009823_7 | Gynecologic disease (multivariate) | 1.0e-08 |
| GCST009829_3 | Ovarian cancer (MTAG) | 5.0e-08 |
| GCST009830_31 | Ovarian cancer | 3.0e-08 |
SUMMARY STATISTICS
| Category | Count |
|---|
| Total Ensembl Transcripts | 47 |
| Total RefSeq Transcripts (mRNA) | 100+ |
| Total CCDS IDs | 5 |
| Total Exons (canonical) | 23 |
| Total UniProt Entries | 22 |
| Total InterPro Domains | 9 |
| Total PDB Structures | 33 |
| Total ClinVar Variants | 15,445 |
| Total AlphaMissense Predictions | 12,463 |
| Total SpliceAI Predictions | 3,719 |
| Total STRING Interactions | 6,120+ |
| Total IntAct Interactions | 342+ |
| Total BioGRID Interactions | 2,598+ |
| Total Reactome Pathways | 27 |
| Total GO Terms | 77 |
| Total GWAS Associations | 7 |
| Total HPO Phenotypes | 166 |
| Total Orphanet Diseases | 9 |
| Total SIGNOR Interactions | 83 |
| Total CollecTRI Regulatory Connections | 140 |
| Total ChEMBL Molecules | 310 |
Reference compiled from: HGNC, Ensembl, NCBI, UniProt, PDB, AlphaFold, ClinVar, AlphaMissense, SpliceAI, STRING, IntAct, BioGRID, Reactome, Gene Ontology, GWAS Catalog, HPO, OMIM, Orphanet, GenCC,
PharmGKB, ChEMBL, Bgee, SIGNOR, CollecTRI, and Single Cell Expression Atlas.